These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32467803)

  • 1. Discoid Lupus Erythematosus Lesions Associated with Systemic Fluorouracil Agents: A Case Report and Review.
    Cohen PR
    Cureus; 2020 Apr; 12(4):e7828. PubMed ID: 32467803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
    Shakhbazova A; Marsch AF
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT).
    Yoshimasu T; Hiroi A; Uede K; Furukawa F
    Eur J Dermatol; 2001; 11(1):54-7. PubMed ID: 11174141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients.
    Callen JP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):278-88. PubMed ID: 3871800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
    Adachi A; Nagai H; Horikawa T
    Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus.
    Chong BF; Song J; Olsen NJ
    Br J Dermatol; 2012 Jan; 166(1):29-35. PubMed ID: 21910708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings.
    Bangert JL; Freeman RG; Sontheimer RD; Gilliam JN
    Arch Dermatol; 1984 Mar; 120(3):332-7. PubMed ID: 6703733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
    Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus-A Pilot Study.
    Király Z; Nagy E; Bokor L; Kovács A; Marschalkó M; Hidvégi B
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. I. Selection of clinical groups and study factors.
    Beutner EH; Blaszczyk M; Jablonska S; Chorzelski TP; Kumar V; Wolska H
    Int J Dermatol; 1991 Jun; 30(6):411-7. PubMed ID: 1894405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
    Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
    Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of generalized discoid lupus erythematosus with imiquimod cream 5%: a case report and review of the literature.
    Turan E; Sinem Bagci I; Turgut Erdemir A; Salih Gurel M
    Acta Dermatovenerol Croat; 2014; 22(2):150-9. PubMed ID: 25102804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Discoid Lupus Erythematosus: More Than what Meets The Eye.
    Pareek S; Mohta A; Mehta RD; Prasad V
    Indian Dermatol Online J; 2023; 14(3):399-401. PubMed ID: 37266098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
    Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
    Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus Band Test in Patients with Borderline Systemic Lupus Erythematosus with Discoid Lesions.
    Akarsu S; Ozbagcivan O; Ilknur T; Semiz F; Lebe B; Fetil E
    Acta Dermatovenerol Croat; 2017 Apr; 25(1):15-21. PubMed ID: 28511745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
    Alexander EL; McNicholl J; Watson RM; Bias W; Reichlin M; Provost TT
    J Invest Dermatol; 1989 Dec; 93(6):751-6. PubMed ID: 2584740
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.